Diametric Capital »

Aeglea Biotherapeutics shares owned by Diametric Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $888k 10k 88.78

More positions owned by Diametric Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Precigen (PGEN)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Fulgent Genetics (FLGT)
Ishares Tr Msci Eafe Etf (EFA)
A2z Cust2mate Solutions Corp (AZ)
Uniqure Nv SHS (QURE)
Liquidia Corporation Com New (LQDA)
Almonty Inds Com New (ALM)
Golar Lng SHS (GLNG)
Calumet (CLMT)
Abivax Sa Sponsored Ads (ABVX)
Digital Realty Trust (DLR)
Telephone & Data Sys Com New (TDS)
MGM Resorts International. (MGM)

View all positions for Diametric Capital

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Perceptive Advisors
Rtw Investments
Paradigm Biocapital Advisors
Vanguard Capital Management
VR Adviser
Driehaus Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Jupiter Topco
TCG Crossover Management
Tang Capital Management
Bank of America Corporation

View all funds holding Aeglea Biotherapeutics